Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.


IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4331
See all formats and pricing

 


Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

New perspectives and strategy research biomarkers for hepatocellular carcinoma

Raphaël Saffroy1 / Patrick Pham2 / Maâmar Reffas3 / Mohamed Takka4 / Antoinette Lemoine5 / Brigitte Debuire6

1Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, Université Paris-Sud, UMR-S602, Villejuif, INSERM, Villejuif, France

2Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, Université Paris-Sud, UMR-S602, Villejuif, INSERM, Villejuif, France

3Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, Université Paris-Sud, UMR-S602, Villejuif, INSERM, Villejuif, France

4Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, Université Paris-Sud, UMR-S602, Villejuif, INSERM, Villejuif, France

5Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, Université Paris-Sud, UMR-S602, Villejuif, INSERM, Villejuif, France

6Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, Université Paris-Sud, UMR-S602, Villejuif, INSERM, Villejuif, France

Corresponding author: Dr. Raphael Saffroy, Service de Biochimie, Biologie Moléculaire et Toxicologie, Hôpital Universitaire Paul Brousse, 14, avenue Paul Vaillant Couturier, 94804 Villejuif cedex, France Phone: +33-1-45596903,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 45, Issue 9, Pages 1169–1179, ISSN (Online) 14374331, ISSN (Print) 14346621, DOI: 10.1515/CCLM.2007.262, September 2007

Publication History

Received:
2007-02-18
Accepted:
2007-05-21
Published Online:
2007-09-11

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Cirrhosis caused by hepatitis B virus, hepatitis C virus or chronic alcohol intake is associated with major risk. Systematic screening for HCC of asymptomatic patients with cirrhosis is needed for earlier detection of small tumors requiring treatment (liver transplantation, surgical resection, percutaneous techniques). The recommended screening strategy among cirrhotic patients is based on regular liver ultrasonography associated with serum α-fetoprotein (AFP) assay. As the performance of AFP is not satisfactory, additional tumoral markers are proposed (des-γ-carboxyprothrombin, glycosylated AFP-L3 fraction). Currently, diagnosis of HCC in cirrhotic patients includes non-invasive tests (imaging after contrast administration, AFP assay); diagnostic biopsy is performed when imaging is limited. After treatment, tumor recurrence is assessed by regular follow-up (AFP assay and imaging). Despite the lack of accurate markers, recent developments in genomic and proteomic approaches will allow the discovery of new biomarkers for primary tumors, as well as for recurrence. This review summarizes the current state of biomarkers for screening, diagnosis and follow-up of HCC, and highlights new perspectives in the field.

Clin Chem Lab Med 2007;45:1169–79.

Keywords: biological markers; cirrhosis; α-fetoprotein; genomic; hepatocellular carcinoma

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
Eric Waidely, Abdul-Rahman Obaid Al-Yuobi, A. S. Bashammakh, Mohammad S. El-Shahawi, and Roger M. Leblanc
The Analyst, 2016, Volume 141, Number 1, Page 36
[3]
Alan Kirwan, Marta Utratna, Michael E. O’Dwyer, Lokesh Joshi, and Michelle Kilcoyne
BioMed Research International, 2015, Volume 2015, Page 1
[4]
Rong Zhu, Jing Yang, Ling Xu, Weiqi Dai, Fan Wang, Miao Shen, Yan Zhang, Huawei Zhang, Kan Chen, Ping Cheng, Chengfen Wang, Yuanyuan Zheng, Jingjing Li, Jie Lu, Yingqun Zhou, Dong Wu, and Chuanyong Guo
Gastroenterology Research and Practice, 2014, Volume 2014, Page 1
[5]
Marko Lempinen, Ilaana Lyytinen, Arno Nordin, Taina Tervahartiala, Heikki Mäkisalo, Timo Sorsa, and Helena Isoniemi
Annals of Medicine, 2013, Volume 45, Number 7, Page 482
[6]
Ilana Lyytinen, Marko Lempinen, Arno Nordin, Heikki Mäkisalo, Ulf-Håkan Stenman, and Helena Isoniemi
Scandinavian Journal of Gastroenterology, 2013, Volume 48, Number 9, Page 1066
[7]
Manar Obada, Marwa Helal, Tarek Abd El Hakeem, Hassan Abd El Hady, and Ahmed Raouf
Egyptian Liver Journal, 2013, Volume 3, Number 3, Page 97
[8]
Min Yao, Deng-Fu Yao, Yin-Zhu Bian, Wei Wu, Xiao-Di Yan, Dan-Dan Yu, Li-Wei Qiu, Jun-Ling Yang, Hai-Jian Zhang, Wen-Li Sai, and Jie Chen
Hepatobiliary & Pancreatic Diseases International, 2013, Volume 12, Number 2, Page 171
[9]
Chang-Yi Lu, Kai-Yuan Lin, Meng-Tsung Tien, Cheng-Tao Wu, Yih-Huei Uen, and Tzu-Ling Tseng
Genes, Chromosomes and Cancer, 2013, Page n/a
[10]
Gaetano Bertino, Annalisa Ardiri, Michele Malaguarnera, Giulia Malaguarnera, Nicoletta Bertino, and Giuseppe Stefano Calvagno
Seminars in Oncology, 2012, Volume 39, Number 4, Page 410
[11]
Franck Chiappini
International Journal of Hepatology, 2012, Volume 2012, Page 1
[12]
Goshi Shiota and Norimasa Miura
Clinical Journal of Gastroenterology, 2012, Volume 5, Number 3, Page 177
[13]
Min Yao, Deng-Fu Yao, Yin-Zhu Bian, Chong-Guo Zhang, Li-Wei Qiu, Wei Wu, Wen-Li Sai, Jun-Ling Yang, and Hai-Jian Zhang
Hepatobiliary & Pancreatic Diseases International, 2011, Volume 10, Number 3, Page 289
[14]
Ying Zhou, Xin Yin, Jun Ying, and BoHeng Zhang
BMC Cancer, 2012, Volume 12, Number 1, Page 17
[15]
O. Rosmorduc
Gastroentérologie Clinique et Biologique, 2009, Volume 33, Number 4, Page 327
[16]
Barbara Adamczyk, Tharmala Tharmalingam, and Pauline M. Rudd
Biochimica et Biophysica Acta (BBA) - General Subjects, 2012, Volume 1820, Number 9, Page 1347
[17]
Evi N. Debruyne and Joris R. Delanghe
Clinica Chimica Acta, 2008, Volume 395, Number 1-2, Page 19
[18]
Zdeněk Kejík, Tomáš Bříza, Jarmila Králová, Pavel Martásek, and Vladimír Král
Analytical and Bioanalytical Chemistry, 2010, Volume 398, Number 5, Page 1865
[19]
Giulia Malaguarnera, Maria Giordano, Isabella Paladina, Massimiliano Berretta, Alessandro Cappellani, and Mariano Malaguarnera
Digestive Diseases and Sciences, 2010, Volume 55, Number 10, Page 2744
[20]
David J. Schutt and Dieter Haemmerich
Medical Physics, 2008, Volume 35, Number 8, Page 3462

Comments (0)

Please log in or register to comment.